Current Gene Therapy

Current Gene Therapy is a peer-reviewed medical journal published by Bentham Science Publishers. The editor-in-chief is Ignacio Anegon (INSERM UMR 1064, Nantes, France). The focus of this journal is pre-clinical or clinical research on gene therapy. Formats of publication include original research reports, review papers, and rapid communications ("letters").[1]

Current Gene Therapy
DisciplineGene therapy
LanguageEnglish
Edited byIgnacio Anegon, MD
Publication details
History2001-present
Publisher
FrequencyBimonthly
5.318 (2012)
Standard abbreviations
ISO 4Curr. Gene Ther.
Indexing
CODENCGTUAH
ISSN1566-5232 (print)
1875-5631 (web)
OCLC no.48623855
Links

Abstracting and indexing

The journal is indexed in:[2][3]

According to the Journal Citation Reports, the journal has a 2012 impact factor of 5.318, ranking it 21st of 161 journals in the category "Genetics & Heredity".[4]

References

  1. Publishers, Bentham Science. "BSP :: Current Gene Therapy". Archived from the original on 3 September 2011. Retrieved 4 August 2011.
  2. "List of indexing services". Current Gene Therapy. Bentham Science Publishers. August 2011. Archived from the original on 2011-09-03. Retrieved 2011-08-04.
  3. "Current Gene Therapy". CASSI. American Chemical Society. August 2011. Missing or empty |url= (help)
  4. "Journals Ranked by Impact: Genetics & Heredity". 2011 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2011.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.